Clinical trial
Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory…
NCT00370422 · Shahid Beheshti University of Medical Sciences, Other · Unknown status
Key facts
| NCT number | NCT00370422 |
|---|---|
| Title | Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial |
| Lead sponsor | Shahid Beheshti University of Medical Sciences, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetic Macular Edema |
| Intervention type | Drug |
| Interventions | Triamcinolone, Bevacizumab |
| Start date | Nov 1, 2005 |
| Completion | Sep 1, 2006 |
| First posted | Aug 31, 2006 |
| Last update posted | Mar 13, 2007 |
| Countries | Iran |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: